CD209 and neoplasm: Additionally, DGEA showed an over-representation of multiple well-known marker genes for tumor-associated macrophages (TAMs) characterized by an immunosuppressive phenotype (also referred as to “M2-like” [48]) in GC BLOWvs GC BHIGH tumors, including the upregulation of CD14 (encoding one of the main differentiation markers of myeloid lineage), CD163, CD209, MRC1 (also known as CD206) and IL4R (Fig. 5A).